about
New analogues of bradykinin containing a conformationally restricted dipeptide fragment in their molecules.Novel analogues of arginine vasopressin containing alpha-2-indanylglycine enantiomers in position 2.Improvement of derivatized amino acid detection sensitivity in micellar electrokinetic capillary chromatography by means of acid-induced pH-mediated stacking technique.Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids.Design, synthesis and biological activity of new neurohypophyseal hormones analogues conformationally restricted in the N-terminal part of the molecule. Highly potent OT receptor antagonists.Arginine-, D-arginine-vasopressin, and their inverso analogues in micellar and liposomic models of cell membrane: CD, NMR, and molecular dynamics studies.Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.Novel Bradykinin Analogues Modified in the N-Terminal Part of the Molecule with a Variety of Acyl Substituents.Analogues of arginine vasopressin modified in the N-terminal part of the molecule with enantiomers of N-methylphenylalanine.Structure of the isoaspartyl peptidase with L-asparaginase activity from Escherichia coli.Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties.New acylated bradykinin analogues: effect on rat blood pressure and rat uterus.Simultaneous determination of scopolamine, hyoscyamine and anisodamine in in vitro growth media of selected Solanaceae hairy roots by CE method.Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations.Tip-enhanced Raman spectroscopy of bradykinin and its B2 receptor antagonists adsorbed onto colloidal suspended Ag nanowires.Studies of the biological properties of human beta-defensin 1.New bradykinin analogs in contraction of rat uterusNew bradykinin analogues substituted in positions 7 and 8 with sterically restricted 1-aminocyclopentane-1-carboxylic acidAnalogs of arginine vasopressin modified in the N-terminal part of the molecule with a conformationally constrained cis-peptide bond motifModifications in the bradykinin main chain are not necessary for antagonistic activity in rat blood pressure assayInfluence of conformationally constrained amino acids replacing positions 2 and 3 of arginine vasopressin (AVP) and its analogues on their pharmacological propertiesThe effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid: a highly potent V2 agonistAnalogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the moleculeHighly potent antidiuretic antagonists: conformational studies of vasopressin analogues modified with 1-naphthylalanine enantiomers at position 2Novel analogues of bradykinin conformationally restricted in the C-terminal part of the moleculeSimultaneous Separation of Eight Benzodiazepines in Human Urine Using Field-Amplified Sample Stacking Micellar Electrokinetic ChromatographyPotent antidiuretic agonists, deamino-vasopressin and desmopressin, and their inverso analogs: NMR structure and interactions with micellar and liposomic models of cell membraneGold nanoparticles dispersion stability under dynamic coating conditions in capillary zone electrophoresisIonic liquids as signal amplifiers for the simultaneous extraction of several neurotransmitters determined by micellar electrokinetic chromatographyEvaluation of sample injection precision in respect to sensitivity in capillary electrophoresis using various injection modes
P50
Q31902768-196E83EE-355E-4CDB-8AD1-287B7A09682EQ33516252-4B677890-F06D-4713-95AF-92F3B7D3B969Q34277741-6089AAE6-1657-4E56-8387-48D38F392A3AQ34418988-70E5EDC9-CC52-476C-A83F-D3E610E4DCC7Q36095654-BAFFC5D7-4926-4A1B-9728-E70E97F632CCQ36236101-DFAE7CC3-F804-4446-B63F-A6B49861B79DQ36306055-422B2532-71A7-4D00-97A0-8B0A213ED39BQ42535719-97DAF716-BEA5-47A1-9A49-0D96AFC99756Q44893896-8F85AB1B-83EA-45CA-98A4-1AD907263DAFQ44908042-D0315B50-134F-46FD-AD69-4A792B40106FQ45218444-7D8CA9DB-40FA-42C3-A6BD-11E484F9E46CQ45293250-31F639B7-9055-4E4E-AFF7-692B1DB90E66Q46687422-2731C48D-76BE-4126-9647-5A62E5460B9FQ50863478-D5FC4BBF-C862-4751-B620-CBF8DF35DD15Q51812812-2CDB6515-A4FB-4D91-BA33-B710B037EBD2Q54452869-1031AB22-48BD-456F-B640-613DE8E66F28Q74223655-12A9CBA2-2D60-421C-A9E9-E10D3A48F123Q79387804-5387C937-F16D-4460-9A74-C1E77CF40CC7Q79405935-59E13B5F-B2A5-411A-B8AE-5372AF47DEC1Q79446040-B390959E-AD42-4BC9-9E80-A2DC2364D479Q79902209-1567D43F-B202-4685-8CC8-BFAE373BA8AFQ80329793-7A955152-B5F2-42FB-89A4-A44CF9088F94Q82836140-127DDE7C-D108-43F0-9DB6-2959C1B6191FQ83414367-4367F9AB-EB25-4D85-A096-BB2E505E6479Q83633507-9799A230-EEC0-4540-9A44-A5D929D92448Q87207103-6FCBD2E2-6404-4F11-AB99-5C72ED345A19Q87372083-03C2F0E2-BC89-442A-B008-1066A45BCC40Q88180104-D5092170-96DF-41D7-83AF-A4AAA5475951Q88762167-6BFB653F-B2F9-4588-A89F-CF357253630DQ89021196-CCB4BDAD-D29F-4DBC-AA02-91296BA62820
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adam Prahl
@ast
Adam Prahl
@en
Adam Prahl
@es
Adam Prahl
@nl
type
label
Adam Prahl
@ast
Adam Prahl
@en
Adam Prahl
@es
Adam Prahl
@nl
prefLabel
Adam Prahl
@ast
Adam Prahl
@en
Adam Prahl
@es
Adam Prahl
@nl
P106
P1153
6602089737
P21
P31
P496
0000-0001-7663-6548